Given that working memory deficits are particularly predictive of long-term functional outcome (71), the influence of elevated CRP on working memory/reasoning suggests that adjunctive anti-inflammatory treatments may reduce cognitive deficits and improve daily function in a substantial subset of patients with schizophrenia. This evidence concerns the gene CRP and schizophrenia.